DLB
Dolby Laboratories
58.60$
+1.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | +118.2% | +31.0% | +25.7% | +34.5% | +33.9% | +20.6% | +7.0% | +11.4% | +4.1% | -11.4% | +14.2% | +7.5% | +8.6% | +9.7% | +12.9% | -1.5% | +4.0% | +6.3% | -13.5% | +10.8% | +4.5% | +3.1% | |
| – | – | – | +37.1% | +213.8% | +26.1% | +28.1% | -5.7% | +30.2% | +17.7% | +9.3% | -16.3% | -16.2% | +23.8% | -8.7% | -17.3% | +33.1% | +28.7% | +6.1% | +12.0% | +13.8% | -25.5% | +13.5% | -19.7% | +16.2% | |
| – | – | – | +27.1% | +373.4% | -70.8% | +17.9% | -5.0% | +9.1% | +17.8% | +152.2% | +18.8% | -3.0% | +25.6% | -6.3% | -2.8% | +22.1% | +45.9% | -12.9% | +34.1% | +14.2% | -49.0% | +30.2% | -29.4% | +21.5% | |
| – | – | – | +329.4% | +40.1% | +30.4% | +23.5% | -14.2% | +43.0% | +15.3% | +11.2% | -15.6% | -25.2% | +34.8% | -16.0% | -4.8% | +37.5% | +25.1% | -16.2% | +21.9% | +12.9% | -35.7% | +17.1% | -39.6% | +21.6% | |
| – | – | – | +54.6% | +36.1% | -29.2% | +19.6% | -1.8% | -16.9% | +151.3% | +20.6% | -29.3% | +114.1% | -14.4% | +24.6% | -31.5% | -1.0% | +339.0% | +15.3% | -11.4% | +21.4% | +1.1% | +5.9% | +15.4% | -0.2% | |
| – | – | – | +69.2% | +63.6% | -5.3% | +34.0% | +21.8% | -28.4% | +118.4% | -7.4% | -36.4% | -39.6% | -15.4% | +62.5% | +17.9% | +53.2% | +4.6% | +23.4% | -21.0% | -57.1% | +114.8% | +51.3% | -5.3% | -9.8% | |
| – | – | – | +10.1% | +5.7% | +0.7% | +11.1% | +2.8% | +4.8% | +2.1% | +24.5% | +117.5% | -4.6% | +19.3% | +39.1% | +10.1% | +9.4% | +6.0% | +4.5% | +0.8% | -1.4% | +4.8% | -6.8% | -0.7% | -2.8% | |
| – | – | – | +152.9% | +8.3% | -2.8% | +69.8% | +536.0% | +4.3% | +1.3% | -0.5% | +6.9% | -0.6% | -0.8% | +10.9% | +0.6% | +0.5% | +5.4% | +2.1% | +0.6% | +1.1% | +7.2% | +11.8% | +30.6% | -0.6% | |
| – | – | – | -52.8% | +153.5% | -13.0% | +136.7% | +134.7% | -1.2% | -18.3% | -23.0% | +9.6% | -26.9% | +54.2% | +100.2% | +68.9% | -11.9% | -3.0% | -1.7% | -15.7% | -19.4% | -8.6% | +49.1% | +159.5% | -8.6% | |
| – | – | – | +2.0% | +5.7% | +13.9% | +40.2% | +50.1% | -9.0% | -9.7% | +1.0% | +9.3% | +9.4% | +6.1% | +25.7% | +6.5% | +17.6% | +25.3% | +2.7% | -2.3% | +3.9% | -13.0% | +38.0% | +3.4% | -7.4% | |
| – | – | – | +25.5% | +12.9% | +27.6% | +54.2% | +40.1% | -22.0% | +5.9% | -3.8% | -1.6% | +10.2% | +9.6% | +10.4% | +1.9% | +15.3% | +10.7% | +12.8% | -13.0% | +18.2% | -12.1% | +52.1% | -1.0% | +4.8% | |
| – | – | – | +22.9% | +4.3% | +7.1% | +8.5% | +1.9% | +1.9% | – | – | – | – | – | – | – | – | – | – | – | -2.6% | -13.9% | +2.8% | -10.2% | -15.1% | |
| – | – | – | -31.7% | 0.0% | -29.9% | +102.6% | +9.2% | +1,022.8% | +30.2% | -13.7% | -88.4% | -27.9% | +48.6% | +30.3% | -15.3% | -18.1% | +52.5% | -30.6% | -17.1% | +40.9% | -20.3% | +47.7% | -16.9% | +2.6% | |
| – | – | – | -6.7% | -10.7% | -10.2% | -11.0% | -19.7% | -25.1% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +52.8% | +221.7% | +28.9% | +34.1% | +31.6% | +27.8% | +11.5% | +11.3% | +3.4% | -13.9% | +15.5% | +5.6% | +9.2% | +8.4% | +2.5% | +5.4% | +5.4% | +6.8% | -13.5% | +4.8% | +5.2% | +5.9% | |
| – | – | – | +46.7% | +41.8% | +50.5% | +53.5% | +48.7% | +39.9% | +33.2% | +27.2% | +18.3% | -14.9% | +14.2% | +8.3% | +7.8% | +7.5% | +2.7% | +8.8% | +5.0% | +6.7% | -11.9% | +4.1% | +4.4% | +5.6% | |
| – | +0.0% | +1.3% | +7.8% | +12.3% | +7.1% | +1.7% | +1.1% | +0.5% | +0.0% | -2.5% | -4.5% | -4.4% | +0.8% | +0.2% | -1.4% | +0.8% | +3.6% | -2.2% | -1.6% | +1.6% | -2.5% | -4.3% | -0.3% | +0.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.